Advertisement

Tissue Engineering and Regenerative Medicine

, Volume 16, Issue 2, pp 141–150 | Cite as

Conditioned Medium Enhances Osteogenic Differentiation of Induced Pluripotent Stem Cell-Derived Mesenchymal Stem Cells

  • Siying Zhong
  • Xufeng He
  • Yuexia Li
  • Xiangxin LouEmail author
Original Article
  • 124 Downloads

Abstract

Background:

Recent studies have shown that induced pluripotent stem cells (iPSCs) could be differentiated into mesenchymal stem cells (MSCs) with notable advantages over iPSCs per se. In order to promote the application of iPSC-MSCs for osteoregenerative medicine, the present study aimed to assess the ability of murine iPSC-MSCs to differentiate into osteoblast phenotype.

Methods:

Osteogenic differentiation medium, blending mouse osteoblast-conditioned medium (CM) with basic medium (BM) at ratio 3:7, 5:5 and 7:3, were administered to iPSC-MSCs, respectively. After 14 days, differentiation was evaluated by lineage-specific morphology, histological stain, quantitative reverse transcription-polymerase chain reaction and immunostaining.

Results:

The osteogenesis-related genes, alp, runx2, col1 and ocn expressions suggest that culture medium consisting of CM:BM at the ratio of 3:7 enhanced the osteogenic differentiation more than other concentrations that were tested. In addition, the alkaline phosphatase activity and osteogenic marker Runx2 expression demonstrate that the combination of CM and BM significantly enhanced the osteogenic differentiation of iPSC-MSCs.

Conclusion:

In summary, this study has shown that osteoblast-derived CM can dramatically enhance osteogenic differentiation of iPSC-MSCs toward osteoblasts. Results from this work will contribute to optimize the osteogenic induction conditions of iPSC-MSCs and will assist in the potential application of iPSC-MSCs for bone tissue engineering.

Keywords

Induced pluripotent stem cells Mesenchymal stem cells Osteoblasts Conditioned medium Osteogenic differentiation 

Notes

Acknowledgements

This work was supported by the Foundation of Shanghai Municipal Natural Science (15ZR1400500) and the Fundamental Research Funds for the Central Universities (2232016A3-04).

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical statement

The study conformed to the principles outlined in the Declaration of Helsinki and was approved by the Scientific Advisory Board and Ethical Review Committee at Donghua University (IRB No. 2013-20).

References

  1. 1.
    Harris JS, Bemenderfer TB, Wessel AR, Kacena MA. A review of mouse critical size defect models in weight bearing bones. Bone. 2013;55:241–7.CrossRefPubMedPubMedCentralGoogle Scholar
  2. 2.
    O’Keefe RJ, Mao J. Bone tissue engineering and regeneration: from discovery to the clinic-an overview introduction. Tissue Eng Part B Rev. 2011;17:389–92.CrossRefPubMedPubMedCentralGoogle Scholar
  3. 3.
    Grässel S, Stöckl S, Jenei-Lanzl Z. Isolation, culture, and osteogenic/chondrogenic differentiation of bone marrow-derived mesenchymal stem cells. Methods Mol Biol. 2012;879:203–67.CrossRefPubMedGoogle Scholar
  4. 4.
    Salgado AJ, Oliveira JT, Pedro AJ, Reis RL. Adult stem cells in bone and cartilage tissue engineering. Curr Stem Cell Res Ther. 2006;1:345–64.CrossRefPubMedGoogle Scholar
  5. 5.
    Havasi P, Nabioni M, Soleimani M, Bakhshandeh B, Parivar K. Mesenchymal stem cells as an appropriate feeder layer for prolonged in vitro culture of human induced pluripotent stem cells. Mol Biol Rep. 2013;40:3023–31.CrossRefPubMedGoogle Scholar
  6. 6.
    Gadkari R, Zhao L, Teklemariam T, Hantash BM. Human embryonic stem cell derived-mesenchymal stem cells: an alternative mesenchymal stem cell source for regenerative medicine therapy. Regen Med. 2014;9:453–65.CrossRefPubMedGoogle Scholar
  7. 7.
    Park S, Im GI. Embryonic stem cells and induced pluripotent stem cells for skeletal regeneration. Tissue Eng Part B Rev. 2014;20:381–91.CrossRefPubMedGoogle Scholar
  8. 8.
    zur Nieden NI, Kempka G, Ahr HJ. In vitro differentiation of embryonic stem cells into mineralized osteoblasts. Differentiation. 2003;71:18–27.CrossRefPubMedGoogle Scholar
  9. 9.
    Karp JM, Ferreira LS, Khademhosseini A, Kwon AH, Yeh J, Langer RS. Cultivation of human embryonic stem cells without the embryoid body step enhances osteogenesis in vitro. Stem Cells. 2006;24:835–43.CrossRefPubMedGoogle Scholar
  10. 10.
    Takahashi K, Yamanaka S. Induction of pluripotent stem cells from mouse embryonic and adult fibroblast cultures by defined factors. Cell. 2006;126:663–76.CrossRefPubMedGoogle Scholar
  11. 11.
    Yu J, Vodyanik MA, Smuga-Otto K, Antosiewicz-Bourget J, Frane JL, Tian S, et al. Induced pluripotent stem cell lines derived from human somatic cells. Science. 2007;318:1917–20.CrossRefPubMedGoogle Scholar
  12. 12.
    Okita K, Yamakawa T, Matsumura Y, Sato Y, Amano N, Watanabe A, et al. An efficient nonviral method to generate integration-free human-induced pluripotent stem cells from cord blood and peripheral blood cells. Stem Cells. 2013;31:458–66.CrossRefPubMedGoogle Scholar
  13. 13.
    Zou L, Luo Y, Chen M, Wang G, Ding M, Petersen CC, et al. A simple method for deriving functional MSCs and applied for osteogenesis in 3D scaffolds. Sci Rep. 2013;3:2243.CrossRefPubMedPubMedCentralGoogle Scholar
  14. 14.
    Chen YS, Pelekanos RA, Ellis RL, Horne R, Wolvetang EJ, Fisk NM. Small molecule mesengenic induction of human induced pluripotent stem cells to generate mesenchymal stem/stromal cells. Stem Cells Transl Med. 2012;1:83–95.CrossRefPubMedPubMedCentralGoogle Scholar
  15. 15.
    Jung Y, Bauer G, Nolta JA. Concise review: induced pluripotent stem cell-derived mesenchymal stem cells: progress toward safe clinical products. Stem Cells. 2012;30:42–7.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Zhang LF, Qi J, Zuo G, Jia P, Shen X, Shao J, et al. Osteoblast-secreted factors promote proliferation and osteogenic differentiation of bone marrow stromal cells via VEGF/heme-oxygenase-1 pathway. PLoS One. 2014;9:e99946.CrossRefPubMedPubMedCentralGoogle Scholar
  17. 17.
    Hwang YS, Randle WL, Bielby RC, Polak JM, Mantalaris A. Enhanced derivation of osteogenic cells from murine embryonic stem cells after treatment with HepG2-conditioned medium and modulation of the embryoid body formation period: application to skeletal tissue engineering. Tissue Eng. 2006;12:1381–92.CrossRefPubMedGoogle Scholar
  18. 18.
    Heino TJ, Hentunen TA, Väänänen HK. Conditioned medium from osteocytes stimulates the proliferation of bone marrow mesenchymal stem cells and their differentiation into ostcoblasts. Exp Cell Res. 2004;294:458–68.CrossRefPubMedGoogle Scholar
  19. 19.
    Jonason JH, O’Keefe RJ. Isolation and culture of neonatal mouse calvarial osteoblasts. Methods Mol Biol. 2014;1130:295–305.CrossRefPubMedGoogle Scholar
  20. 20.
    Wu Y, Qin C, Yu Z, Wang X, Zhang Y, Lou X. Nanofibrous scaffold containing osteoblast-derived extracellular matrix for the proliferation of bone marrow mesenchymal stem cells. J Donghua Univ. 2017;34:756–60.Google Scholar
  21. 21.
    Maxson S, Burg KJ. Conditioned media cause increases in select osteogenic and adipogenic differentiation markers in mesenchymal stem cell cultures. J Tissue Eng Regen Med. 2008;2:147–54.CrossRefPubMedGoogle Scholar
  22. 22.
    Xie J, Lou X, Wang X, Yang L, Zhang Y. Electrospun nanofibers of hydroxyapatite/collagen/chitosan promote osteogenic differentiation of the induced pluripotent stem cell-derived mesenchymal stem cells. J Control Release. 2015;213:e53.CrossRefPubMedGoogle Scholar
  23. 23.
    Granholm S, Henning P, Lindholm C, Lerner UH. Osteoclast progenitor cells present in significant amounts in mouse calvarial osteoblast isolations and osteoclastogenesis increased by BMP-2. Bone. 2013;52:83–92.CrossRefPubMedGoogle Scholar
  24. 24.
    Teramura T, Onodera Y, Mihara T, Hosoi Y, Hamanishi C, Fukuda K. Induction of mesenchymal progenitor cells with chondrogenic property from mouse-induced pluripotent stem cells. Cell Reprogram. 2010;12:249–61.CrossRefPubMedGoogle Scholar
  25. 25.
    Villa-Diaz LG, Brown SE, Liu Y, Ross AM, Lahann J, Parent JM, et al. Derivation of mesenchymal stem cells from human induced pluripotent stem cells cultured on synthetic substrates. Stem Cells. 2012;30:1174–81.CrossRefPubMedPubMedCentralGoogle Scholar
  26. 26.
    Lian Q, Zhang Y, Zhang J, Zhang HK, Wu X, Zhang Y, et al. Functional mesenchymal stem cells derived from human induced pluripotent stem cells attenuate limb ischemia in mice. Circulation. 2010;121:1113–23.CrossRefPubMedGoogle Scholar
  27. 27.
    Zhou Y, Yu D, Zhu H. Optimization of culture condition of human bone marrow stromal cells in terms of purification, proliferation, and pluripotency. In Vitro Cell Dev Biol Anim. 2014;50:822–30.CrossRefPubMedGoogle Scholar
  28. 28.
    Bilousova G, Jun du H, King KB, De Langhe S, Chick WS, Torchia EC, et al. Osteoblasts derived from induced pluripotent stem cells form calcified structures in scaffolds both in vitro and in vivo. Stem Cells. 2011;29:206–16.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Li F, Niyibizi C. Cells derived from murine induced pluripotent stem cells (iPSC) by treatment with members of TGF-beta family give rise to osteoblasts differentiation and form bone in vivo. BMC Cell Biol. 2012;13:35.CrossRefPubMedPubMedCentralGoogle Scholar
  30. 30.
    Okano H, Nakamura M, Yoshida K, Okada Y, Tsuji O, Nori S, et al. Steps toward safe cell therapy using induced pluripotent stem cells. Circ Res. 2013;112:523–33.CrossRefPubMedGoogle Scholar
  31. 31.
    Takahashi K, Yamanaka S. Induced pluripotent stem cells in medicine and biology. Development. 2013;140:2457–61.CrossRefPubMedGoogle Scholar
  32. 32.
    Ye CP, Heng BC, Liu H, Toh WS, Cao T. Culture media conditioned by heat-shocked osteoblasts enhances the osteogenesis of bone marrow-derived mesenchymal stromal cells. Cell Biochem Funct. 2007;25:267–76.CrossRefPubMedGoogle Scholar
  33. 33.
    Hayashi T, Misawa H, Nakahara H, Noguchi H, Yoshida A, Kobayashi N, et al. Transplantation of osteogenically differentiated mouse iPS cells for bone repair. Cell Transplant. 2012;21:591–600.CrossRefPubMedGoogle Scholar
  34. 34.
    Ko JY, Park S, Im GI. Osteogenesis from human induced pluripotent stem cells: an in vitro and in vivo comparison with mesenchymal stem cells. Stem Cells Dev. 2014;23:1788–97.CrossRefPubMedGoogle Scholar
  35. 35.
    Maxson S, Burg KJ. Conditioned media enhance osteogenic differentiation on poly(L-lactide-co-epsilon-caprolactone)/hydroxyapatite scaffolds and chondrogenic differentiation in alginate. J Biomater Sci Polym Ed. 2010;21:1441–58.CrossRefPubMedGoogle Scholar
  36. 36.
    Maxson S, Burg KJ. Synergistic effects of conditioned media and hydrostatic pressure on the differentiation of mesenchymal stem cells. Cell Mol Bioeng. 2012;5:414–26.CrossRefGoogle Scholar
  37. 37.
    Birmingham E, Niebur GL, McHugh PE, Shaw G, Barry FP, McNamara LM. Osteogenic differentiation of mesenchymal stem cells is regulated by ostroblast cells in a simplified bone niche. Eur Cell Mater. 2012;23:13–27.CrossRefPubMedGoogle Scholar
  38. 38.
    Gimble JM, Nuttall ME. Bone and fat: old questions, new insights. Endocrine. 2004;23:183–8.CrossRefPubMedGoogle Scholar
  39. 39.
    Ji XH, Chen D, Xu C, Harris SE, Mundy GR, Yoneda T. Patterns of gene expression associated with BMP-2-induced osteoblast and adipocyte differentiation of mesenchymal progenitor cell 3T3-F442A. J Bone Miner Metab. 2000;18:132–9.CrossRefPubMedGoogle Scholar
  40. 40.
    Rawadi G, Vayssière B, Dunn F, Baron R, Roman-Roman S. BMP-2 controls alkaline phosphatase expression and osteoblast mineralization by a Wnt autocrine loop. J Bone Miner Res. 2003;18:1842–53.CrossRefPubMedGoogle Scholar
  41. 41.
    Gupta RR, Yoo DJ, Hebert C, Niger C, Stains JP. Induction of an osteocyte-like phenotype by fibroblast growth factor-2. Biochem Biophys Res Commun. 2010;402:258–64.CrossRefPubMedPubMedCentralGoogle Scholar
  42. 42.
    Wang T, Wang Y, Menendez A, Fong C, Babey M, Tahimic CG, et al. Osteoblast-specific loss of IGF1R signaling results in impaired endochondral bone formation during fracture healing. J Bone Miner Res. 2015;30:1572–84.CrossRefPubMedPubMedCentralGoogle Scholar
  43. 43.
    Huynh N, VonMoss L, Smith D, Rahman I, Felemban MF, Zuo J, et al. Characterization of regulatory extracellular vesicles from osteoclasts. J Dent Res. 2016;95:673–9.CrossRefPubMedPubMedCentralGoogle Scholar

Copyright information

© The Korean Tissue Engineering and Regenerative Medicine Society and Springer Nature B.V. 2019

Authors and Affiliations

  1. 1.Department of Bioengineering, College of Chemistry, Chemical Engineering and BiotechnologyDonghua UniversityShanghaiChina
  2. 2.Key Laboratory of Science and Technology of Eco-Textiles, Ministry of Education, College of Chemistry, Chemical Engineering and BiotechnologyDonghua UniversityShanghaiChina
  3. 3.Department of DermatologyShuguang Hospital Affiliated to Shanghai University of Traditional Chinese MedicineShanghaiChina

Personalised recommendations